Siying Li Selected Research

S-allylmercaptocysteine

4/2020	S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
1/2020	S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway.
5/2018	S-allylmercaptocysteine attenuates posaconazole-induced adverse effects in mice through antioxidation and anti-inflammation.
9/2017	Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
1/2017	S-allylmercaptocysteine suppresses the growth of human gastric cancer xenografts through induction of apoptosis and regulation of MAPK and PI3K/Akt signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Siying Li Research Topics

Disease

14	Neoplasms (Cancer) 02/2022 - 01/2017
11	Inflammation (Inflammations) 10/2021 - 04/2013
3	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 11/2019
3	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 11/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 02/2020 - 10/2016
2	COVID-19 12/2021 - 11/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2019 - 02/2019
2	Fibrosis (Cirrhosis) 11/2019 - 01/2012
2	Body Weight (Weight, Body) 02/2019 - 06/2018
2	Carcinoma (Carcinomatosis) 02/2019 - 01/2017
2	Infarction (Infarctions) 03/2018 - 04/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2015 - 12/2012
1	Non-alcoholic Fatty Liver Disease 08/2022
1	Dermatitis 04/2022
1	Headache (Headaches) 01/2022
1	Endophthalmitis (Ophthalmia) 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022
1	Macular Edema 01/2022
1	Cytokine Release Syndrome 12/2021
1	Dysbiosis 10/2021
1	Hyperglycemia 06/2021
1	Hyperlipidemias (Hyperlipidemia) 06/2021
1	Hepatitis B 05/2020
1	Acute Lung Injury 04/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Osteoarthritis 01/2020
1	Anorectal Malformations 01/2020
1	Atherosclerosis 01/2020

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2017
5	S-allylmercaptocysteineIBA 04/2020 - 01/2017
4	Therapeutic UsesIBA 04/2020 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 07/2015
3	Ergosterol (Lumisterol)IBA 02/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2022 - 10/2021
2	AntibodiesIBA 01/2022 - 12/2021
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 04/2013
2	Transferrin Receptors (Transferrin Receptor)IBA 10/2021 - 01/2021
2	LigandsIBA 01/2021 - 11/2019
2	LipopolysaccharidesIBA 04/2020 - 10/2016
2	NF-kappa B (NF-kB)IBA 04/2020 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 02/2019
2	yifei tongluoIBA 02/2019 - 12/2016
2	CytokinesIBA 01/2019 - 07/2017
2	Neuroprotective AgentsIBA 01/2019 - 03/2018
2	Pharmaceutical PreparationsIBA 05/2018 - 03/2018
2	Cysteine (L-Cysteine)FDA Link 09/2017 - 10/2016
2	diallyl trisulfideIBA 07/2017 - 01/2017
2	Cadherins (E-Cadherin)IBA 07/2017 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 01/2017
1	oil red OIBA 08/2022
1	Nonesterified Fatty Acids (NEFA)IBA 08/2022
1	MicroRNAs (MicroRNA)IBA 08/2022
1	AntagomirsIBA 08/2022
1	Imiquimod (Aldara)FDA LinkGeneric 04/2022
1	Iodide Peroxidase (Deiodinase)IBA 01/2022
1	Thyroglobulin FDA Link 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 12/2021
1	Peptides (Polypeptides)IBA 10/2021
1	IntegrinsIBA 10/2021
1	Polystyrenes (Polystyrene)IBA 10/2021
1	16S Ribosomal RNAIBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	MicroplasticsIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	Interleukin-10 (Interleukin 10)IBA 10/2021
1	tumstatin (74-98)IBA 01/2021
1	lactate dehydrogenase C4IBA 01/2021
1	AGRO 100IBA 01/2021
1	Nanoparticle Drug Delivery SystemIBA 01/2021
1	NucleolinIBA 01/2021
1	AlbuminsIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Transferrin (beta 2 Transferrin)IBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2021
1	Infliximab (Remicade)FDA Link 11/2020
1	Tenofovir (Viread)FDA Link 05/2020
1	wogoninIBA 03/2020
1	Cyclin D1IBA 03/2020
1	Glycogen Synthase (Synthase I)IBA 03/2020
1	Biological ProductsIBA 03/2020
1	Glycogen Synthase Kinase 3 betaIBA 03/2020
1	ResveratrolIBA 01/2020
1	ethyleneIBA 01/2020
1	CollagenIBA 01/2020
1	LuciferasesIBA 01/2020
1	CholesterolIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Volatile Organic CompoundsIBA 01/2020
1	EthylenethioureaIBA 01/2020
1	ThioureaIBA 01/2020

Therapy/Procedure

8	Therapeutics 10/2021 - 01/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2019 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2016
1	Injections 01/2022